Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

gamitrinib (Gam-05)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Accanito Therapeutics, Fox Chase Cancer Center, The Wistar Institute

Drug class:

HSP90 inhibitor

Related drugs: